Osr Health, Inc. (OSRH) Stock Price & Analysis

Osr Health, Inc. (OSRH) fell 8.16% to USD 0.23 as of September 8, 2026 at 10:16 UTC, according to Nexqual real-time market data.

OSRH last closed at USD 0.23; the session ranged USD 0.2–0.26 on volume of 318,676 shares. Market capitalization is —, with a 52-week range of USD 0.08–0.91 (NCM). Source: Nexqual, September 8, 2026 at 10:16 UTC.

Key Statistics (as of September 8, 2026 at 10:16 UTC)

Technical Analysis (OSRH)

Nexqual's technical model rates OSRH "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 10:16 UTC.

From Osr Health, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)

Key Strengths & Strategy (as disclosed to the SEC)

• VXM01 and the underlying proprietary platform, further, has the potential to target multiple indications, even beyond oncology.   VXM01 has recently completed a Phase 2 clinical trial in Europe for the treatment of recurrent glioblastoma, where activity has been observed to date.

Partnerships

• We collaborate with academic and industry leaders to promote a seamless integration and partnership between entrepreneurial scientists and seasoned business development and leadership teams.
• RMC's distribution agreement with Penumbra Inc. for the resale of its reperfusion catheter, neuron delivery catheter and related tubing and canister, expired on June 30, 2024.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:16 UTC. This page is informational and not investment advice.